Skip to content
Isabl logo

Isabl

Isabl is a YC Winter 2020 (W20) company. Based in New York, NY, USA; Remote. Team of 5.

  • Biotech
  • Diagnostics

About Isabl

GPAgent's own fund-neutral profile, written from public information. Updated Oct 5, 2026.

Summary

Isabl builds whole-genome and transcriptome sequencing software for cancer diagnostics, replacing narrow panel-based genetic tests that examine only a handful of mutations. Oncology labs run a tumor biopsy through a sequencer and Isabl's platform analyzes the complete genome and transcriptome, surfacing every cancer-associated mutation in the sample. This gives clinicians and researchers a fuller picture of tumor biology to guide treatment decisions, disease surveillance, and biomarker discovery.

Business model

SaaS fee for access to the whole-genome and transcriptome sequencing analysis platform (WGTS SaaS)

Go-to-market

Isabl targets cancer genomics labs, molecular diagnostic teams, and oncology researchers; prospective customers engage through a scheduled meeting with the sales team.

From the Y Combinator listing

How Isabl describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

Cancer tests based on whole genome and transcriptome data.

Isabl has developed software that can analyze the entire genome of cancer patients. Today, when people get cancer, they get a genetic test of their tumor that analyzes only a few possible mutations. With Isabl, you run the tumor through an Illumina sequencer and get the whole genome, then our software is able to analyze all the mutations. Our breakthrough technology provides unprecedented clarity into tumor biology to aid treatment planning. This opens up opportunities for precision diagnostics, disease surveillance and biomarker discovery.

Facts

Industry
Healthcare / Healthcare -> Diagnostics
Location
New York, NY, USA; Remote
Team size
5
Status
Active
Stage
Early

Founders (3)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works